{
    "pmcid": "7992133",
    "qa_pairs": {
        "How does RosettaAntibody achieve accurate prediction of CDR loops, particularly HCDR3?": [
            "Using template selection, loop grafting, and de novo loop modeling",
            "Employing molecular dynamics simulations and energy minimization",
            "Applying machine learning algorithms for sequence analysis",
            "Utilizing cryo-EM data for structural refinement"
        ],
        "What is the primary focus of the Rosetta software suite as described in the paper?": [
            "Designing SARS-CoV-2 nanobody binders",
            "Predicting RNA secondary structures",
            "Simulating metabolic pathways",
            "Analyzing genomic sequences"
        ],
        "What is the role of SnugDock in the Rosetta suite?": [
            "Refining CDR loops and VH\u2013VL orientations in antibody-antigen complexes",
            "Predicting the secondary structure of RNA molecules",
            "Modeling the folding pathways of membrane proteins",
            "Designing small molecule inhibitors for viral proteins"
        ],
        "What is the significance of the RosettaCarbohydrate framework in the context of SARS-CoV-2?": [
            "Modeling and design of glycosylated proteins like the SARS-CoV-2 spike protein",
            "Predicting the binding affinity of small molecules to viral enzymes",
            "Simulating the immune response to viral infections",
            "Designing lipid nanoparticles for vaccine delivery"
        ],
        "Which specific protocols does Rosetta provide for antibody modeling?": [
            "RosettaAntibody, AbPredict, and RosettaCM",
            "RosettaLigand, RosettaFold, and RosettaRNA",
            "RosettaDock, SnugDock, and RosettaDesign",
            "RosettaMembrane, RosettaCarbohydrate, and RosettaEpitope"
        ]
    }
}